KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Fulgent Genetics (FLGT) over the last 8 years, with Q3 2025 value amounting to -$864000.0.

  • Fulgent Genetics' Deferred Taxes rose 6335.88% to -$864000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 4864.11%. This contributed to the annual value of -$3.7 million for FY2024, which is 13258.33% down from last year.
  • As of Q3 2025, Fulgent Genetics' Deferred Taxes stood at -$864000.0, which was up 6335.88% from -$113000.0 recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Deferred Taxes ranged from a high of $19.4 million in Q3 2023 and a low of -$5.5 million during Q1 2022
  • In the last 5 years, Fulgent Genetics' Deferred Taxes had a median value of -$864000.0 in 2025 and averaged -$518315.8.
  • Per our database at Business Quant, Fulgent Genetics' Deferred Taxes crashed by 59936.39% in 2022 and then soared by 61652.5% in 2023.
  • Quarter analysis of 5 years shows Fulgent Genetics' Deferred Taxes stood at -$1.6 million in 2021, then crashed by 107.31% to -$3.3 million in 2022, then skyrocketed by 115.0% to $502000.0 in 2023, then crashed by 172.51% to -$364000.0 in 2024, then plummeted by 137.36% to -$864000.0 in 2025.
  • Its Deferred Taxes was -$864000.0 in Q3 2025, compared to -$113000.0 in Q2 2025 and -$133000.0 in Q1 2025.